Opioid dependence: buprenorphine prolonged-release injection (Buvidal)-evidence summary (ES19)

Source:
National Institute for Health and Care Excellence - NICE
Publisher:
National Institute for Health and Care Excellence
Publication date:
14 February 2019

Abstract

Review suggests this may be an option where there is risk of diversion/concerns about safety of medicines at home, or for people who have difficulties adhering to daily supervised opioid substitution medication, or in custodial settings, but comes at higher drug acquisition cost